Ocular Therapeutix
Price & Volume
Stats
See more52W Range | $6.23-$16.44 |
Market Cap | $2.2B |
Shares Short | 26M |
Financials
See moreRevenue (12 Mos) | $52M |
Revenue Growth (YoY) | 0.8% |
Gross Profit (12 Mos) | -$175M |
Diluted EPS | -$1.44 |
News
See moreYahoo Finance • 5 days ago
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • 13 days ago
William Blair updates conviction list: Oracle in, Meta out and more
Yahoo Finance • 13 days ago
Ocular Therapeutix™ to Participate in July Scientific and Investor Conferences
Yahoo Finance • 19 days ago
Is Ocular Therapeuticx, Inc. (OCUL) Stock Positioned for Growth After Positive FDA Feedback on Axpaxli?
About
CEO | Dr. Pravin U. Dugel M.D. |
CFO | Mr. Jason Robins |
Address | 14 Crosby Drive, Bedford, MA, United States, 01730 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 325 |